LINACS
Living Systematic Review on the Safety of
Stereotactic Radiotherapy
within 30 days of New Anticancer Therapies
Search drug or drug group
Study design
RT–Drug Timing Window
Click a card to explore the data
Adverse Events Overview
Grade ≥3 Adverse Events by Drug Group
Bubble size = number of patients · click a bubble to open the group page
OVERALL AEs
AE within or outside irradiated organs
RT-RELATED
AE within irradiated organs
About LINACS
This project originated within and is housed by the EORTC-ESTRO OligoCare consortium. LINACS is a living systematic review providing continuously updated evidence on adverse events following combined stereotactic radiotherapy and novel anticancer therapies.
Learn more →
Disclaimer:
The LINACS website does not provide medical advice, diagnosis, or treatment. It is intended to support
healthcare professionals and not to replace clinical judgment. While it may support clinical decision-making,
it does not provide definitive guidance on treatment combinations for individual patients.
The authors and platform are not liable for any clinical decisions based on the presented data.